Search Result "hypoplastic myelodysplastic syndrome"
Myelodysplastic Syndromes: Review of Pathophysiology and Current Novel Treatment Approaches
Journal: Current Cancer Drug Targets
Volume: 7 Issue: 6 Year: 2007 Page: 541-558
Author(s): E. D. Warlick, B. D. Smith
World Health Organization Classification of Myelodysplastic Syndromes
Journal: Current Pharmaceutical Design
Volume: 18 Issue: 22 Year: 2012 Page: 3149-3162
Author(s): Magdalena Czader,Attilio Orazi
Strategies for Biology- and Molecular-Based Treatment of Myelodysplastic Syndromes
Journal: Current Drug Targets
Volume: 6 Issue: 6 Year: 2005 Page: 713-725
Author(s): E. H. Lindberg
Single Autosomal Trisomy in Acute Myeloid Leukemia and Myelodysplastic Syndrome
Journal: Current Genomics
Volume: 1 Issue: 2 Year: 2000 Page: 153-173
Author(s): S. K. Ma, T. S.K. Wan
Immunomodulatory Drugs (IMiDs™): A New Treatment Option for Myelodysplastic Syndromes
Journal: Current Pharmaceutical Biotechnology
Volume: 7 Issue: 5 Year: 2006 Page: 339-342
Author(s): Vishakha Kale, Alan F. List
Impact of Immunogenetic Polymorphisms in Bone Marrow Failure Syndromes
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2011 Page: 544-552
Author(s): B. Serio, C. Selleri, J. P. Maciejewski
Cancer Therapy-Induced Residual Bone Marrow Injury: Mechanisms of Induction and Implication for Therapy
Journal: Current Cancer Therapy Reviews
Volume: 2 Issue: 3 Year: 2006 Page: 271-279
Author(s): Yong Wang, Virginia Probin, Daohong Zhou
Novel Immunosuppressive Strategies for Bone Marrow Failure Syndromes: A Focus on Alemtuzumab
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 11 Issue: 6 Year: 2011 Page: 536-543
Author(s): C. Selleri, B. Serio, A. M. Risitano
Myeloproliferative Neoplasms Including Polycythemia Vera, Essential Thrombocythemia, and Primary Myelofibrosis, Chronic Neutrophilic Leukemia, and Myeloproliferative Neoplasm, Unclassifiable
Journal: Current Cancer Therapy Reviews
Volume: 8 Issue: 1 Year: 2012 Page: 14-29
Author(s): Robert P. Hasserjian
Role of Immunomodulatory Drugs in the Treatment of Lymphoid and Myeloid Malignancies
Ebook: Frontiers in Clinical Drug Research: Hematology
Volume: 3 Year: 2018
Author(s): Ota Fuchs
Doi: 10.2174/9781681083674118030005